BACTEROIDES LPS/CYTOKINE REGULATION IN INFLAMED GINGIVAL TISSUE
发炎牙龈组织中拟杆菌脂多糖/细胞因子的调节
基本信息
- 批准号:6296247
- 负责人:
- 金额:$ 4.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-01 至 2000-04-30
- 项目状态:已结题
- 来源:
- 关键词:Bacteroides Bacteroides gingivalis bactericidal immunity biopsy cytokine enzyme linked immunosorbent assay fibroblasts gene expression gingiva human tissue immunocytochemistry immunopathology in situ hybridization inflammation interleukin 1 interleukin 6 interleukin 8 laboratory mouse leukocyte activation /transformation lipopolysaccharides macrophage messenger RNA monocyte neutralizing antibody oral bacteria periodontitis polymerase chain reaction tissue /cell culture tumor necrosis factor alpha
项目摘要
Periodontitis is a chronic inflammatory disease of periodontal tissues
in which the black-pigmented Bacteroides species, particularly
Porphyromonas (Bacteroides) gingivalis, have been implicated as etiologic
agents. Microbial components of the Bacteroides, including their
lipopolysaccharide (LPS), have been implicated in the initial infiltrate
of lymphocytes, monocytes/macrophages and neutrophils which is
characteristic of this disease. However, the microbial and host related
mechanisms involved are not fully understood. Bacterial LPS has the
ability to activate host cells for the production of inflammatory factors
such as interleukin-1 (IL-1), tumor-necrosis factor-alpha (TNF-alpha),
IL-6, IL-8 and IL-1 inhibitor. IL-8 is a chemoattractant for PMNs and
T lymphocytes and its production is induced by TNF-alpha, IL-1 and LPS.
Therefore, IL-8 along with other cytokines and microbial LPS may be
involved in self-amplifying loops in promoting cellular events associated
with inflammatory disease. It is likely that modulation of cellular
function is mediated by changes in gene expression which can result from
direct stimulation by LPS and/or by cellular products such as IL-1, TNF-
alpha or IFN-gamma. Classical LPS (e.g., LPS derived from Escherichia
coli) is a potent inducer of cytokines, especially IL-1, but only
recently have we begun to understand the molecular mechanisms involved
in LPS activation of cells and in the induction and regulation of
cytokine production. The LPS of the Bacteroides is structurally
different from and is less potent than classical LPS. Therefore, the
manner in which these different LPS molecules interact with cells for
activation is likely to be different. the overall objectives of the
studies proposed in this application are to demonstrate that Bacteroides
LPS stimulates host cells to produce inflammatory cytokines; that the
mechanisms of stimulation differ from those involved with classical LPS;
and that eh developmental stage and the source of cells influence the
profile of cytokines which can be produced. Specifically, we will (1)
determine the differences in the ability of Bacteroides LPS compared to
classical LPS to stimulate human monocytes/macrophages and gingival and
dermal fibroblasts to produce the inflammatory cytokines IL-1, TNF-alpha,
IL-6 and IL-8, as well as IL-1 inhibitor. Dose response and time course
studies will be performed to determine the induction sequence of message
and protein and the amount of each factor produced following in vitro
incubation of cells with LPS or LPS and cytokines. Cytokine-specific
mRNA will be identified by the reverse PCR method and the levels of
cytokines produced will be assessed in functional assays and by ELISA.
We will also (2) determine whether differences exist in the profile of
cytokines produced by gingival fibroblasts derived from healthy and
granulomatous tissue and from the periodontal ligament following in vitro
stimulation with Bacteroides LPS. Finally, we will (3) determine the
cellular production of IL-1, IL-1 inhibitor, TNF-alpha, IL-6 and IL-8 by
in situ hybridization for cytokine-specific mRNA in gingival biopsies
obtained from patients with periodontitis and determine if detection of
cytokine mRNA correlates with the level of each cytokine detected in
crevicular fluid samples obtained from these subjects. Immunohistologic
techniques will be used to define the cellular composition of tissue
biopsies. These studies will provide evidence for the mechanism(s) by
which Bacteroides LPS stimulates host cells and will define the
contribution of this microbial LPS, cytokines and their inhibitors in
mediating events occurring in inflamed periodontal tissues. Taken
together, these studies should help us understand the cellular events
that take place in inflamed tissue which will help in the development of
better methods for treatment and prevention of periodontitis as well as
other inflammatory diseases.
牙周炎是牙周组织的慢性炎症性疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suzanne M. Michalek其他文献
Cellular events leading to immunity following ingestion of food antigen
- DOI:
10.1016/s0091-6749(73)80082-x - 发表时间:
1973-02-01 - 期刊:
- 影响因子:
- 作者:
Richard M. Rothberg;Sumner C. Kraft;Suzanne M. Michalek - 通讯作者:
Suzanne M. Michalek
Polymer vesicles for the delivery of inhibitors of cariogenic biofilm
- DOI:
10.1016/j.dental.2024.09.006 - 发表时间:
2024-11-01 - 期刊:
- 影响因子:
- 作者:
Parmanand Ahirwar;Veronika Kozlovskaya;Piyasuda Pukkanasut;Pavel Nikishau;Sarah Nealy;Gregory Harber;Suzanne M. Michalek;Linto Antony;Hui Wu;Eugenia Kharlampieva;Sadanandan E. Velu - 通讯作者:
Sadanandan E. Velu
Suzanne M. Michalek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suzanne M. Michalek', 18)}}的其他基金
Development of a Mucosal Vaccine Against F. tularensis
土拉弗朗西斯粘膜疫苗的研制
- 批准号:
6864867 - 财政年份:2003
- 资助金额:
$ 4.21万 - 项目类别:
Development of a Mucosal Vaccine Against F. tularensis
土拉弗朗西斯粘膜疫苗的研制
- 批准号:
6798161 - 财政年份:2003
- 资助金额:
$ 4.21万 - 项目类别:
Development of a Mucosal Vaccine Against F. tularensis
土拉弗朗西斯粘膜疫苗的研制
- 批准号:
7029667 - 财政年份:2003
- 资助金额:
$ 4.21万 - 项目类别:
Development of a Mucosal Vaccine Against Francisella tularensis
土拉弗朗西斯菌粘膜疫苗的研制
- 批准号:
7209733 - 财政年份:2003
- 资助金额:
$ 4.21万 - 项目类别:
Development of a Mucosal Vaccine Against F. tularensis
土拉弗朗西斯粘膜疫苗的研制
- 批准号:
6689492 - 财政年份:2003
- 资助金额:
$ 4.21万 - 项目类别:
BACTEROIDES LPS/CYTOKINE REGULATION IN INFLAMED GINGIVAL TISSUE
发炎牙龈组织中拟杆菌脂多糖/细胞因子的调节
- 批准号:
6104731 - 财政年份:1998
- 资助金额:
$ 4.21万 - 项目类别:
BACTEROIDES LPS/CYTOKINE REGULATION IN INFLAMED GINGIVAL TISSUE
发炎牙龈组织中拟杆菌脂多糖/细胞因子的调节
- 批准号:
6270281 - 财政年份:1997
- 资助金额:
$ 4.21万 - 项目类别:
GENETICALLY ENGINEERED ORAL VACCINES AND CARIES IMMUNITY
基因工程口服疫苗和龋齿免疫
- 批准号:
2130299 - 财政年份:1996
- 资助金额:
$ 4.21万 - 项目类别:
Genetically Engineered Oral Vaccines & Caries Immunity
基因工程口服疫苗
- 批准号:
6708881 - 财政年份:1996
- 资助金额:
$ 4.21万 - 项目类别:
Genetically Engineered Oral Vaccines & Caries Immunity
基因工程口服疫苗
- 批准号:
6634618 - 财政年份:1996
- 资助金额:
$ 4.21万 - 项目类别:
相似海外基金
BSL-3 EMERGING PATHOGENS RES FACIL: ORAL BACTEROIDES, GINGIVALIS
BSL-3 新发病原体研究工具:口腔拟杆菌、牙龈杆菌
- 批准号:
7153803 - 财政年份:2005
- 资助金额:
$ 4.21万 - 项目类别:














{{item.name}}会员




